Population
Human embryonic kidney 293 cells
Design
Preclinical
Authors
Loading...
Should not alter clinical practice; leaves open intracellular prostacyclin-PPAR delta signaling as a cell-fate regulator for further validation.
Prostacyclin can act through endogenous PPAR delta as a second signaling pathway that controls cell fate, promoting apoptosis when formed intracellularly.
Hatae et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: